L233-1029 Screening compound: 5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methyl-N-[(5-methyl-1H-1,3-benzodiazol-2-yl)methyl]thiophene-3-sulfonamide

L233-1029 Screening compound: 5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methyl-N-[(5-methyl-1H-1,3-benzodiazol-2-yl)methyl]thiophene-3-sulfonamide
L233-1029 Screening compound: 5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methyl-N-[(5-methyl-1H-1,3-benzodiazol-2-yl)methyl]thiophene-3-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L233-1029
5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methyl-N-[(5-methyl-1H-1,3-benzodiazol-2-yl)methyl]thiophene-3-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L233-1029

Molecular Formula

C22H18FN5O3S2 (C22 H18 FN5 O3 S2)

Compound Name

5-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-2-methyl-N-[(5-methyl-1H-1,3-benzodiazol-2-yl)methyl]thiophene-3-sulfonamide

IUPAC name

5-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]-2-methyl-N-[(5-methyl-1H-13-benzodiazol-2-yl)methyl]thiophene-3-sulfonamide

SMILES

Cc(sc(-c1nc(-c(cc2)ccc2F)no1)c1)c1S(NCc1nc(cc(C)cc2)c2[nH]1)(=O)=O

InChI

InChI=1S/C22H18FN5O3S2/c1-12-3-8-16-17(9-12)26-20(25-16)11-24-33(29,30)19-10-18(32-13(19)2)22-27-21(28-31-22)14-4-6-15(23)7-5-14/h3-10,24H,11H2,1-2H3,(H,25,26)

InChI Key

OOHZNVHLEGSICJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27237342

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.55

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.460

Distribution Coefficient, logD

5.397

Water Solubility, LogSw

-5.47

Polar Surface Area

94.702

Acid Dissociation Constant (pKa)

8.29

Base Dissociation Constant (pKb)

5.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.60

L233-1029 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • Receptor's ligands
Structure:
  • Mimetics
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Others
  • GPCR

References: we are preparing a list of scientific research reports with L233-1029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L233-1029?
Check Price and Availability of L233-1029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L233-1029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L233-1029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L233-1029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L233-1029 available by request